Cargando…

National introduction of HPV vaccination in Senegal—Successes, challenges, and lessons learned ()

Following successful school-based demonstration programs in 2014–2016, the human papillomavirus (HPV) vaccine was introduced nationwide in Senegal for 9-year-old girls in 2018, using a routine service delivery strategy at health facilities, schools, and other outreach sites. We reviewed the HPV vacc...

Descripción completa

Detalles Bibliográficos
Autores principales: Casey, Rebecca M., Adrien, Nedghie, Badiane, Ousseynou, Diallo, Aliou, Roka, Jerlie Loko, Brennan, Timothy, Doshi, Reena, Garon, Julie, Loharikar, Anagha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662429/
https://www.ncbi.nlm.nih.gov/pubmed/34593269
http://dx.doi.org/10.1016/j.vaccine.2021.08.042
_version_ 1785148538221494272
author Casey, Rebecca M.
Adrien, Nedghie
Badiane, Ousseynou
Diallo, Aliou
Roka, Jerlie Loko
Brennan, Timothy
Doshi, Reena
Garon, Julie
Loharikar, Anagha
author_facet Casey, Rebecca M.
Adrien, Nedghie
Badiane, Ousseynou
Diallo, Aliou
Roka, Jerlie Loko
Brennan, Timothy
Doshi, Reena
Garon, Julie
Loharikar, Anagha
author_sort Casey, Rebecca M.
collection PubMed
description Following successful school-based demonstration programs in 2014–2016, the human papillomavirus (HPV) vaccine was introduced nationwide in Senegal for 9-year-old girls in 2018, using a routine service delivery strategy at health facilities, schools, and other outreach sites. We reviewed the HPV vaccine introduction in Senegal to understand the successes, challenges, and lessons learned. Focusing on three key domains (program decision-making, planning, and implementation), we conducted ten semi-structured interviews during 2019–2020 with purposively selected national-level stakeholders (government, expert advisory committee, key technical and implementation partners) and comprehensive desk reviews of country documents on HPV vaccine introduction. Due to the global HPV vaccine shortage, the introduction was limited to a single-age cohort; therefore, 9-year-old girls were chosen. This strategy enabled Senegal to potentially reach more girls in primary education because school enrolment rates decline thereafter. Vaccination through routine delivery platforms (i.e., health facility, school-based, and community outreach) was perceived to be more cost-effective than a campaign approach. High-level political commitment and collaborations between immunization and education partners were frequently cited by key informants as reasons for a successful vaccine introduction. All key informants reported that the health care worker (HCW) strike, rumors, and vaccine hesitancy negatively impacted the introduction. Other challenges noted included insufficient information on attitudes towards HPV vaccination among HCWs, teachers, and community members. Senegal successfully introduced HPV vaccine into the national immunization schedule, using a routine delivery strategy. Strong leadership and a multi-sectoral approach likely contributed to this success. To build sustainability of the HPV vaccination program in the future, it is important to improve the understanding and engagement among all stakeholders, including HCWs and community members, and to strengthen and innovate communication and crisis management strategies. To better understand the efficiency and effectiveness of Senegal’s vaccination strategy, additional assessments of the operational costs and coverage achieved are needed.
format Online
Article
Text
id pubmed-10662429
institution National Center for Biotechnology Information
language English
publishDate 2022
record_format MEDLINE/PubMed
spelling pubmed-106624292023-11-21 National introduction of HPV vaccination in Senegal—Successes, challenges, and lessons learned () Casey, Rebecca M. Adrien, Nedghie Badiane, Ousseynou Diallo, Aliou Roka, Jerlie Loko Brennan, Timothy Doshi, Reena Garon, Julie Loharikar, Anagha Vaccine Article Following successful school-based demonstration programs in 2014–2016, the human papillomavirus (HPV) vaccine was introduced nationwide in Senegal for 9-year-old girls in 2018, using a routine service delivery strategy at health facilities, schools, and other outreach sites. We reviewed the HPV vaccine introduction in Senegal to understand the successes, challenges, and lessons learned. Focusing on three key domains (program decision-making, planning, and implementation), we conducted ten semi-structured interviews during 2019–2020 with purposively selected national-level stakeholders (government, expert advisory committee, key technical and implementation partners) and comprehensive desk reviews of country documents on HPV vaccine introduction. Due to the global HPV vaccine shortage, the introduction was limited to a single-age cohort; therefore, 9-year-old girls were chosen. This strategy enabled Senegal to potentially reach more girls in primary education because school enrolment rates decline thereafter. Vaccination through routine delivery platforms (i.e., health facility, school-based, and community outreach) was perceived to be more cost-effective than a campaign approach. High-level political commitment and collaborations between immunization and education partners were frequently cited by key informants as reasons for a successful vaccine introduction. All key informants reported that the health care worker (HCW) strike, rumors, and vaccine hesitancy negatively impacted the introduction. Other challenges noted included insufficient information on attitudes towards HPV vaccination among HCWs, teachers, and community members. Senegal successfully introduced HPV vaccine into the national immunization schedule, using a routine delivery strategy. Strong leadership and a multi-sectoral approach likely contributed to this success. To build sustainability of the HPV vaccination program in the future, it is important to improve the understanding and engagement among all stakeholders, including HCWs and community members, and to strengthen and innovate communication and crisis management strategies. To better understand the efficiency and effectiveness of Senegal’s vaccination strategy, additional assessments of the operational costs and coverage achieved are needed. 2022-03-31 2021-09-27 /pmc/articles/PMC10662429/ /pubmed/34593269 http://dx.doi.org/10.1016/j.vaccine.2021.08.042 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Article
Casey, Rebecca M.
Adrien, Nedghie
Badiane, Ousseynou
Diallo, Aliou
Roka, Jerlie Loko
Brennan, Timothy
Doshi, Reena
Garon, Julie
Loharikar, Anagha
National introduction of HPV vaccination in Senegal—Successes, challenges, and lessons learned ()
title National introduction of HPV vaccination in Senegal—Successes, challenges, and lessons learned ()
title_full National introduction of HPV vaccination in Senegal—Successes, challenges, and lessons learned ()
title_fullStr National introduction of HPV vaccination in Senegal—Successes, challenges, and lessons learned ()
title_full_unstemmed National introduction of HPV vaccination in Senegal—Successes, challenges, and lessons learned ()
title_short National introduction of HPV vaccination in Senegal—Successes, challenges, and lessons learned ()
title_sort national introduction of hpv vaccination in senegal—successes, challenges, and lessons learned ()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662429/
https://www.ncbi.nlm.nih.gov/pubmed/34593269
http://dx.doi.org/10.1016/j.vaccine.2021.08.042
work_keys_str_mv AT caseyrebeccam nationalintroductionofhpvvaccinationinsenegalsuccesseschallengesandlessonslearned
AT adriennedghie nationalintroductionofhpvvaccinationinsenegalsuccesseschallengesandlessonslearned
AT badianeousseynou nationalintroductionofhpvvaccinationinsenegalsuccesseschallengesandlessonslearned
AT dialloaliou nationalintroductionofhpvvaccinationinsenegalsuccesseschallengesandlessonslearned
AT rokajerlieloko nationalintroductionofhpvvaccinationinsenegalsuccesseschallengesandlessonslearned
AT brennantimothy nationalintroductionofhpvvaccinationinsenegalsuccesseschallengesandlessonslearned
AT doshireena nationalintroductionofhpvvaccinationinsenegalsuccesseschallengesandlessonslearned
AT garonjulie nationalintroductionofhpvvaccinationinsenegalsuccesseschallengesandlessonslearned
AT loharikaranagha nationalintroductionofhpvvaccinationinsenegalsuccesseschallengesandlessonslearned